ABSTRACT 1,2-Dichloropropane (1,2-DCP) has been used as a paint remover in the industry. The International Agency for Research on Cancer reclassified this compound recently to group 1 (carcinogenic to humans) based on epidemiological studies of cholangiocarcinoma among offset-color proof-printing workers exposed to 1,2-DCP in Japan. Two-year rodent carcinogenicity bioassays demonstrated that 1,2-DCP induced tumors in liver and lung, but not in bile duct. The present study was designed to assess the toxic effects of 1,2-DCP on proliferation and apoptosis in mice bile duct and the role of cytochrome P450 (CYP450) in any such effect. Male C57BL/6JJcl mice were cotreated or untreated with 1-aminobenzotriazole (1-ABT), a CYP450 inhibitor, and exposed to inhalation of 1,2-DCP at 0, 50, or 250 ppm alone, or at 0, 50, 250, or 1250 ppm 8 h/day for 4 weeks. Exposure to 1,2-DCP increased proliferation and apoptosis of cholangiocytes and induced severe hepatic damage, but had no effect on the lungs. Cotreatment with 1-ABT abrogated the effects of 1,2-DCP on proliferation and apoptosis of cholangiocytes. The results revealed that 1,2-DCP induces proliferation and apoptosis of cholangiocytes and that this effect is mediated through CYP450.
.
The carcinogenicity of 1,2-DCP has been investigated in experimental animals. In these studies, lung and liver tumors were found in mice, and nasal cavity tumors were detected in rats (Matsumoto et al., 2013; NTP, 1986; Umeda et al., 2010) . Furthermore, subchronic exposure to 1,2-DCP was also found to have non-carcinogenic hepatotoxic effects in rats and mice, such as hepatic necrosis, swelling, fatty degeneration and inflammatory cell infiltration (Bruckner et al., 1989; Matsumoto et al., 2013; NTP, 1986; Trevisan et al., 1989; Umeda et al., 2010) . However, 1,2-DCP is reported to have no effects on cholangiocyte proliferation in mice and hamsters (Gi et al., 2015a (Gi et al., , 2015b Zhang et al., 2015) . Thus, there is only little information on 1,2-DCP-related biliary carcinogenesis.
Dihaloalkanes including dichloroethane and dibromoethane are known to form reactive episulfonium ion by conjugating with glutathione (GSH), resulting in adduct formation of DNA (Guengerich 2003 , Guengerich et al., 1987 , but a study using D 6 -DCP (Bartels and Timchalk 1990) failed to provide evidence for the formation of episulfonium ion in the metabolism of 1,2-DCP in rats. Our previous study also failed to explain the species difference in cancer site based on the distribution of glutathione S-transferase (GST) (Zhang et al., 2015) . In contrast to the possible involvement of the GSH pathway in 1,2-DCP carcinogenicity, a recent study showed that cytochrome P450 (CYP450), specifically cytochrome P450 2E1 (CYP2E1)-mediated oxidative metabolism of 1,2-DCP contributed to hepatotoxicity (Yanagiba et al., 2016) , but to our knowledge, there is currently no sufficient evidence on the relationship between metabolism of 1,2-DCP and the effects on bile ducts (Gi et al., 2015a (Gi et al., , 2015b Zhang et al., 2015) .
The present study was designed to determine the effects of 1,2-DCP on the proliferation and apoptosis of cholangiocytes in mice. Using 1-aminobenzotriazole (1-ABT), a nonselective CYP450 inhibitor, the study also investigated the role of CYP450 in the observed effects of 1,2-DCP on cholangiocytes.
MATERIALS AND METHODS
Chemicals. 1,2-DCP (purity !99.0%) was obtained from Fulka Analytical, Sigma-Aldrich Co. (St. Louis, MO). 1-ABT (purity > 98.0%) was obtained from Tokyo Chemical Industry Co. (Tokyo, Japan). 5-bromo-2-deoxyuridine (BrdU) was obtained from Sigma-Aldrich Co.
Animals and exposure. Forty-two 10-week-old male C57BL/6JJcl mice were obtained from Clea, Inc. (Tokyo, Japan). The animals were housed individually in stainless steel cages in a temperature-controlled (23 C-25 C) and relative humidity-controlled (55%-60%) room under a 12/12-h light/dark cycle. Food and water were provided ad libitum. All mice were acclimated to the animal room environment for 1 week before experimentation. Based on our previous studies (Zhang et al., 2015; Zong et al., 2016) , we selected 250 ppm as the maximum tolerated concentration of 1,2-DCP for mice untreated with 1-ABT, and 1250 ppm for mice cotreated with 1-ABT. Forty-two mice were randomly allocated into 7 groups of 6 mice each. Mice of 4 groups were injected SC with 1-ABT at 50 mg/kg body weight in normal saline twice a day at 9 AM and 700 PM every day from 3 days before the start of the 4-week exposure to 1,2-DCP at 0, 50, 250, and 1250 ppm until the end of 4-week exposure to 1,2-DCP. Those of the other 3 groups were injected with normal saline at 5 ml/kg body weight as vehicle during the same time course as mice cotreated with 1-ABT, and exposed to 1,2-DCP at 0, 50, and 250 ppm. Mice were exposed to 1,2-DCP by an inhalation exposure system for 8 h/day from 10 AM to 6 PM, 7 day/week, for 4 weeks.
The inhalation exposure system was described in detail previously (Ichihara et al., 2000) . Briefly, 1,2-DCP was vaporized and mixed with filtered fresh air to achieve the target concentration. The concentration of 1,2-DCP in the exposure chamber was monitored by gas chromatography and digitally controlled to within 65% of the target concentration. The mean concentration measured every 10 s for 8 h was considered the values for a given day. The daily gas concentrations in the 3 chambers measured were 58 6 8 ppm, 260 6 25 ppm, and 1240 6 97 ppm (mean 6 SD), respectively.
This study was conducted according to the Japanese law on the protection and control of animals and the Animal Experimental Guidelines of Nagoya University. The experimental protocol was also approved by the Animal Ethics Committee of Nagoya University Medical School.
Animal necropsies and sample collection. Within 15-23 h after the end of the 4-week exposure, mice were weighed and euthanized using an overdose of pentobarbital. In order to evaluate cell proliferation, each mouse was injected IP with BrdU at 100 mg/kg body weight in normal saline, 1 h before euthanasia. After withdrawal of blood from the abdominal aorta, the liver, lungs, and testes were dissected out and weighed. Next, a 5-mm-thick strip At the end of the experiment. Data are mean 6 SD, n ¼ 6 (for 1,2-DCP 1250 ppm 1-ABT injection group, n ¼ 5). *p < .05, compared with the corresponding control by 1-way ANOVA followed by Dunnett's test (2-tailed). **p < .05, compared with the corresponding 1-ABT-untreated group exposure to 1,2-DCP at the same concentration by 2-way ANOVA followed by Bonferroni test.
Abbreviations: 1,2-DCP, 1,2-dichloropropane; 1-ABT, 1-aminobenzotriazole.
of the liver tissue containing the portal section, left lateral lobe, and the median lobe and the right lung were obtained and fixed in 4% paraformaldehyde for histopathological analysis. The remaining liver and left lung were snap frozen on dry ice and stored at À80 C until use for biochemical analysis. The testis was fixed with Bouin's solution as a positive control for immunohistochemical staining. Plasma biochemical tests were outsourced to SRL Inc. (Tokyo, Japan).
Microsomal CYP2E1 activity in liver and lung. Microsomes were prepared from the liver and left lung and used for determination of CYP2E1 activity using the methods described in detail previously (Zong et al., 2016) . Briefly, 0.1-0.2 g of liver or lung tissue was homogenized in ice-cold buffer. The homogenized tissue was centrifuged at 18 500 Â g, at 4 C for 15 min. The supernatant was then centrifuged at 86 000 Â g, at 4 C for 60 min. The obtained sediment was resuspended in 250 mM sucrose. Protein concentration was determined using a protein assay kit (Bio-Rad Laboratories, Inc., Hercules, CA) with Pierce Bovine Serum Albumin Standard Pre-Diluted Set (Thermo Fisher Scientific Inc., Waltham, MA). For microsomal CYP2E1 activity assay, 0.3 mg microsomes and 20 lg chlorzoxazone (CZX), a substrate of CYP2E1, were incubated in 1 ml of reaction buffer for 20 min at 37 C. The 3.2 6 0.9 5.6 6 4.2 6.0 6 2.4 4.1 6 0.7 8.2 6 9.5 6.8 6 1.2 13 6 4.5* Alanine transferase (10 IU/l) 1.3 6 0.3 2.2 6 1.4 2.8 6 0.7* 3.1 6 1.1 3.3 6 2.2 3.8 6 0.6 5.7 6 3.2 Alkaline phosphatase (10 2 IU/l) 1.4 6 0.3 1.7 6 0.4 1.8 6 0.4 2.0 6 0.2** 2.1 6 0.7 1.8 6 0.2 2.5 6 1.0 Lactate dehydrogenase (10 2 IU/l) 3.0 6 2.0 3.1 6 1.3 2.8 6 0.8 2.4 6 0.6 2.4 6 0.9 2.9 6 1.0 3.4 6 1.1 Total bilirubin (10 À2 mg/dl) 3 6 1 3 6 1 5 6 2* 4 6 1 3 6 2 3 6 1 8 6 5* a Number of mice alive at the end of the study. *p < .05, compared with the corresponding control by 1-way ANOVA followed by Dunnett's test (2-tailed). **p < .05, compared with the corresponding 1-ABT-untreated group exposure to 1,2-DCP at the same concentration by 2-way ANOVA followed by Bonferroni test.
Abbreviations: 1,2-DCP, 1,2-dichloropropane; 1-ABT, 1-aminobenzotriazole. *Significantly different from the corresponding control at p < .05 by 1-way ANOVA followed by Dunnett's test (2-tailed).
Abbreviations: CZX, chlorzoxazone; OH-CZX, 6-hydroxychlorzoxazone; 1,2-DCP, 1,2-dichloropropane; 1-ABT, 1-aminobenzotriazole; CYP2E1, cytochrome P450 2E1. *Significantly different from the corresponding control at p < .05 by 1-way ANOVA followed by Dunnett's test (2-tailed).
Abbreviations: 1,2-DCP, 1,2-dichloropropane; 1-ABT, 1-aminobenzotriazole;
CDNB, 1-chloro-2,4-dinitrobenzene; GST, glutathione S-transferase.
reaction was stopped by adding 200 ll of acetonitrile containing phenacetin (15 lg/ml), an internal standard. After centrifugation at 10 000 Â g for 4 min, the supernatant was mixed with 2 ml diethyl ether, vortexed, and centrifuged at 2000 Â g for 1 min to separate the layers. The diethyl ether layer was dried under vacuum. The residues were reconstituted with 150 ll of mobile phase: a mixture of 0.05% phosphoric acid and acetonitrile at a ratio of 86: 14, vol/vol, and vortexed for the test. The Hewlett
Packard HP 1100 HPLC analysis system (Hewlett Packard, Palo Alto, CA) with photodiode array detector and the Hewlett Packard ODS Hypersil column (5 lm, 125 Â 4 mm) were used for detection. Then, 100 ll of the sample was injected into the HPLC column and the flow rate was set at 1 ml/min. Column temperature was kept at 30 C and UV absorbance was measured at 287 nm. Mixtures of different concentrations of 6-hydroxychlorzoxazone (OH-CZX; Sigma-Aldrich) and phenacetin (15 lg/ml) in Figure 1 . Microsomal CYP2E1 and cytosolic GST activity in liver and lung. A, CYP2E1 activity. In the liver, CYP2E1 activity was increased in a dose-dependent manner after 4-week exposure to 1,2-DCP in the absence of 1-ABT treatment. 1-ABT effectively inhibited CYP2E1 activity in both the liver and lung. B, GST activity. GST activity in the liver increased in a dose-dependent manner by 1,2-DCP in the absence of 1-ABT treatment. Under 1-ABT treatment, no obvious change was observed in GST activity after 1,2-DCP exposure. Data are mean 6 SD. *p < .05, by 2-way ANOVA followed by Bonferroni test. Abbreviations: 1,2-DCP, 1,2-dichloropropane; 1-ABT, 1-aminobenzotriazole; CYP2E1, cytochrome P450 2E1; GST, glutathione S-transferase. the mobile phase were used to prepare a standard curve. CYP2E1 activity was expressed as the amount of metabolite OH-CZX produced by 1 mg microsomal protein per minute.
Cytosolic GST activity in liver and lung. GST activity was measured with the GST Activity Assay Kit (Colorimetric, ab65326; Abcam, Cambridge, UK), based on the instructions provided by the manufacturer. The microsome preparation was subjected to ultracentrifugation, as described above, and the supernatant was used for GST assay. GST activity was expressed as the amount of GSH-conjugated substrate of 1-chloro-2, 4-dinitrobenzne produced per minute by 1 mg of protein.
Histopathological examination. Fixed tissue blocks were embedded in paraffin. Liver and testis sections were cut into 5-lm-thick sections and processed for hematoxylin and eosin (H&E) or immunohistochemical staining. Lung sections were cut at a thickness of 4 lm for H&E staining. Tissue slices were examined by optical microscopy.
Immunohistochemical analysis of cell proliferation in liver. The proliferation of cholangiocytes and hepatocytes was evaluated by immunohistochemical staining for BrdU and Ki-67. BrdU immunostaining was performed using the BrdU Immunohistochemistry Kit (ab125306; Abcam). The rabbit polyclonal anti-Ki-67 antibody (#ab15580; Abcam, 1:250 dilution) and the rabbit-specific HRP/ DAB (ABC) Detection IHC Kit (ab64261; Abcam) were used for Ki-67 immunostaining. Immunoreactivity was detected by the streptavidin-biotin-peroxidase complex method, according to the protocol supplied by the manufacturer. Omission of the primary antibody served as the negative control while the stained testis sections served as the positive controls. For cholangiocytes, the BrdU labeling index and Ki-67 index were determined by counting the number of BrdU-labeled cells and Ki-67-positive cells divided by the total number of cholangiocytes in each section for 1 sample and multiplying by 100, respectively. The mean number of bile ducts examined for BrdU-and Ki-67-positive cells in all mice was 93 6 18 and 95 6 18, respectively (6SD). For hepatocytes, the BrdU-and Ki-67-positive cells were quantified by counting the numbers of cells with positively stained nuclei within the whole area of 1 section per mouse. The density of cells was expressed per square centimeter. Cells were counted under an optical microscope at Â10 magnification by an examiner blinded to the exposure groups.
Immunohistochemical analysis of cell apoptosis in liver. The TUNEL assay with the DeadEnd Colorimetric TUNEL System Kit (G7130; Promega Co., Madison, WI) was conducted to detect apoptotic cholangiocytes and hepatocytes, using the instructions recommended by the manufacturer. The apoptotic nuclei were stained dark brown by the HRP/DAB (ABC) detection system. DNase I-procured-DNA fragmentation (12 U/ll, Nippongene, Tokyo, Japan) served as the positive control. TUNEL-positive cells were counted in the same manner as BrdU-and Ki-67-positive cells. The mean number of the examined bile ducts in all mice was 93 6 16 (6SD).
Western blot. Liver protein samples were prepared as described in detail in our previous study (Zong et al., 2016) . In this analysis, 12% Mini-PROTEAN TGX Precast Gels (Bio-Rad Laboratories, Inc.) and PVDF membranes were used. Furthermore, rabbit anti-caspase-3 (#ab184787; Abcam, 1:2000 dilution) and rabbit anti-c-H2AX (phosphor S139) (#ab2893; Abcam, 1:1000 dilution) antibodies were used as the primary antibodies. Mouse anti-b-actin antibody (A1978; Sigma-Aldrich, 1:4000 dilution) was used as the loading control. After incubation with appropriate secondary antibodies, the protein bands were visualized by ECL reagents. Images were taken by Fusion Solo Imaging System (Viber Lourmat, Collegien, France) and analyzed by ImageJ software. The protein expression levels were normalized relative to the level of b-actin protein on the same membrane.
Statistical analysis. Data were reported as mean 6 SD. Differences among groups were analyzed by 1-or 2-way ANOVA followed by Dunnett's test (2-tailed) or Bonferroni test for multiple comparisons. When normality or variance equality failed, a KruskalWallis ranked test was conducted. Differences in the incidence Paraffin-embedded liver sections were processed for routine H&E staining.
Severe focal necrosis with hemorrhage and inflammatory cell infiltration in the liver parenchyma were found in the 50 and 250 ppm 1,2-DCP-exposed groups untreated with 1-ABT and in 250 and 1250 ppm-1,2-DCP-exposed mice treated with 1-ABT. Normal liver (A); note the areas of focal necrosis (arrows) (C, E, F, and H). Hepatocyte fatty changes (arrowheads) were observed in mice exposed of hepatic histopathological changes between the control and 1,2-DCP exposed groups were examined by the Fisher's exact test and linear trend chi-square test. P values less than 0.05 were considered statistically significant. All statistical procedures were performed using the IBM SPSS Statistics software V22.0 (IBM Corporation, Armonk, NY). Table 1 provides data on the survival rate and body and liver weights of mice. One 1-ABT-treated mouse died during the third week of exposure to 1,2-DCP at 1250 ppm. In 1-ABT-treated mice, the body weight of those exposed to 1,2-DCP at 1250 ppm was significantly lower than the control mice at the end of the 4-week experiment. Changes in body weight are illustrated in Supplementary Figure 1 . Liver weight increased significantly after exposure to 1,2-DCP at 250 ppm in 1-ABT-untreated mice. However, with 1-ABT treatment, there was no difference in liver weight between the 1,2-DCP exposed and control mice. Treatment with 1-ABT significantly increased the liver weight of mice unexposed to 1,2-DCP. Table 2 and Supplementary Table 1 show changes in aspartate aminotransferase (AST), alanine transferase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase, total bilirubin (TBIL), and total bile acid. In 1-ABT-untreated mice, ALT and TBIL increased significantly after exposure to 1,2-DCP at 250 ppm. Similarly, in 1-ABT-treated mice, AST and TBIL were significantly high after exposure to 1,2-DCP at 1250 ppm. No significant differences were found in the measured other parameters.
RESULTS

General Findings
Biochemical Changes
Microsomal CYP2E1 and Cytosolic GST Activity in Liver and Lung
The results of CYP2E1 and GST activity are shown in Tables 3 and 4 , respectively, and Figure 1 . In the liver of 1-ABT-untreated mice, CYP2E1 activity increased dose-dependently with 1,2-DCP, with a significant change at 250 ppm. In mice cotreated with 1-ABT, CYP2E1 activity did not change after exposure to 1,2-DCP at 0, 50, and 250 ppm, although it significantly increased at 1250 ppm. Cotreatment with 1-ABT decreased CYP2E1 activity in mice exposed to 1,2-DCP at 50 and 250 ppm, compared with mice untreated with 1-ABT and exposed to 1,2-DCP at the same concentrations.
On the other hand, in mice untreated with 1-ABT, GST activity also increased dose-dependently with 1,2-DCP, with a significant change at 250 ppm. It is noteworthy that GST activity did Magnification: Â40. Scale bar: 50 lm. B, Positive controls of stained testicular sections. Magnification: Â10. Scale bar: 200 lm. C, Both BrdU labeling index and Ki-67 index tended to increase with higher concentrations of 1,2-DCP in 1-ABT-untreated mice, but such increases were suppressed by 1-ABT. 1-ABT treatment reduced the proliferation of cholangiocytes in mice exposed to 1,2-DCP at 250 ppm. Data are mean 6 SD. *p < .05, by 2-way ANOVA followed by Bonferroni test. Abbreviations: BrdU, 5-bromo-2-deoxyuridine; 1,2-DCP, 1,2-dichloropropane; 1-ABT, 1-aminobenzotriazole. not change after 1,2-DCP exposure in 1-ABT-treated mice, although it increased at 0 and 50 ppm, compared with mice untreated with 1-ABT and exposed to 1,2-DCP at the same concentrations, respectively.
In the lung, 1,2-DCP exposure neither changed CYP2E1 nor GST activity, regardless of treatment with 1-ABT. Cotreatment with 1-ABT significantly decreased CYP2E1 activity, compared with mice exposed to 1,2-DCP at 50 and 250 ppm. Cotreatment with 1-ABT did not change GST activity in mice exposed to 1,2-DCP regardless of its concentration. Table 5 provides a summary of the data of this part of the study. Focal necrosis with hemorrhage and inflammatory cell infiltration was observed in the liver parenchyma of 2 mice of the 1-ABT-untreated mice that were exposed to 1,2-DCP at 50 ppm and 3 mice exposed to 250 ppm (Figs. 2C and 2E) . However, in the 1-ABT-cotreated mice, severe focal necrosis was observed in 1 mouse exposed to 1,2-DCP at 250 ppm and 3 mice at 1250 ppm, but was not observed at 50 ppm (Figs. 2F and 2H ). Hepatocyte fatty changes were observed in 1-ABT treated mice, except for the mice exposed to 1,2-DCP at 1250 ppm (Figs. 2B, 2D, and 2G) . In all groups, microabscesses with lymphocyte and/or neutrophil infiltration were occasionally found in the centrilobular, midzonal, and periportal area. Mild intrahepatic bile duct hyperplasia was observed in the Glisson's sheath of mice irrespective of treatment with 1-ABT (Supplementary Figure 2) . Nevertheless, the incidence of hyperplasia in intrahepatic bile duct correlated linearly with 1,2-DCP exposure dose in mice untreated with 1-ABT (Table 5) . No histopathological changes were found in the lung of mice exposed to 1,2-DCP irrespective of treatment with 1-ABT (Supplementary Figure 3) .
Histopathological Changes
Cholangiocyte Proliferation
BrdU-and Ki-67-positive cells were clearly identified in the liver sections as well as in the positive control testicular samples photomicrographs of hepatocytes stained for Ki-67. Arrowheads: BrdU-or Ki-67-positive hepatocytes. Magnification: Â10. Scale bar: 200 lm. B, The density of Ki-67-positively stained hepatocytes tended to increase with higher concentrations of 1,2-DCP in 1-ABT-untreated mice, but such increase was suppressed by 1-ABT. 1-ABT reduced the proliferation of hepatocytes in mice exposed to 1,2-DCP at 250 ppm. Data are mean 6 SD. *p < .05, by 2-way ANOVA followed by Bonferroni test.
Abbreviations: BrdU, 5-bromo-2-deoxyuridine; 1,2-DCP, 1,2-dichloropropane; 1-ABT, 1-aminobenzotriazole. (Figs. 3A and 3B) . In 1-ABT-untreated mice, both the BrdU labeling index and Ki-67 index increased significantly with the concentration of 1,2-DCP. However, there were no significant differences in 1-ABT-cotreated mice exposed to 1,2-DCP compared with the control. In addition, 1-ABT reduced the proliferation of cholangiocytes in mice exposed to 1,2-DCP at 250 ppm ( Figure 3C ).
Hepatocyte Proliferation
Proliferation of hepatocyte was evaluated by immunohistochemical staining of BrdU and Ki-67 (Figure 4 ). There were no significant differences in the density of BrdU-positive hepatocytes among the different groups. In 1-ABT-untreated mice, the density of Ki-67-positive hepatocytes was significantly higher in animals exposed to 1,2-DCP at 250 ppm. Cotreatment with 1-ABT significantly decreased the density of Ki-67-positive hepatocytes in mice exposed to 1,2-DCP at 250 ppm.
Apoptosis of Cholangiocytes
TUNEL-positive cells were identified among cholangiocytes ( Figure 5A ). The TUNEL index tended to increase with the concentration of 1,2-DCP; in particular, the difference between 1250 ppm 1,2-DCP exposed mice and control mice treated with 1-ABT was significant ( Figure 5C ). Intriguingly, cotreatment with 1-ABT reduced cholangiocyte apoptosis in mice exposed to 1,2-DCP at 0 and 250 ppm.
Apoptosis of Hepatocytes
The TUNEL assay was used to quantitate apoptotic hepatocytes after 1,2-DCP exposure (Figs. 6A and 6B ). There were no significant differences in the density of TUNEL-positive hepatocytes between 1,2-DCP exposed mice and control mice irrespective of 1-ABT treatment. Western blot results did not show any change in the protein expression of caspase-3 in the liver of animals exposed to 1,2-DCP, regardless of 1-ABT treatment ( Figure 6C ).
DISCUSSION
Exposure of C57BL/6J mice to 1,2-DCP induced (1) proliferation and apoptosis of cholangiocytes accompanied by bile duct hyperplasia and (2) proliferation of hepatocytes. Administration of 1-ABT significantly inhibited CYP2E1 activity in the liver and edly reduced apoptosis of cholangiocytes in control mice and 1,2-DCP-exposed mice at 250 ppm. The TUNEL index tended to increase with 1,2-DCP exposure level but only the difference between 1250 ppm 1,2-DCP exposed-mice and control mice treated with 1-ABT was significant. Data are mean 6 SD. *p < .05, by 2-way ANOVA followed by Bonferroni test. Abbreviations: 1,2-DCP, 1,2-dichloropropane; 1-ABT, 1-aminobenzotriazole. attenuated the effect of 1,2-DCP on proliferation of cholangiocytes and hepatocytes and apoptosis of cholangiocytes. The CYP450-mediated oxidative metabolism of 1,2-DCP was suggested to be responsible for not only proliferation but also apoptosis of cholangiocytes, which might be involved in the carcinogenic process.
Treatment with 1-ABT effectively reduced CYP2E1 activity in both the liver and lung, but it increased GST activity in the liver. Considering the amelioration of the impact of the hepatobiliary system by 1-ABT, the results highlight the important role of CYP450 in the bioactivation and toxicity of 1,2-DCP.
Cholangiocytes are normally mitotically quiescent, but proliferate in response to specific pathological stimuli or toxins, leading to biliary diseases associated with dysregulation of the balance between cholangiocyte proliferation and apoptosis (Glaser et al., 2010; LeSage et al., 1999) , which are important components of the tumorigenesis process (Foster, 2000; SchulteHermann et al., 1999; Strazzabosco et al., 2005) . In the present study, we employed 2 markers for cell proliferation: the exogenous BrdU, a marker of S-phase in the cell cycle, and the endogenous nuclear protein Ki-67, a marker of G (1)-, S-, G (2)-, and M-phases (Tanaka et al., 2011) . Interestingly, less apoptotic cells were found in 1-ABT-treated mice that were not exposed to 1,2-DCP, suggesting that cellular CYP450 might maintain homeostasis and background apoptosis. CYP450 levels might affect various signal transduction pathways that alter the cell cycle, causing apoptosis or aberrant cell growth and thereby tumorigenesis (Nebert and Dalton, 2006) .
Blood biochemical tests showed that 1,2-DCP dosedependently increased TBIL and ALT in 1-ABT-untreated mice, but this change was abrogated by 1-ABT. While the increase in TBIL might reflect bile duct dysfunction, it should be carefully interpreted since no sufficient data are available on unconjugated bilirubin, a marker of hemolysis. One group reported significant increase in serum 5 0 -nucleotidase, c-glutamyl transpeptidase and ALP in 1,2-DCP-treated rats, suggesting the development of intrahepatic cholestasis (Imberti et al., 1990) , but the present study did not show any 1,2-DCP-related change in ALP. TUNEL-positive hepatocytes between 1,2-DCP exposed mice and control mice with or without 1-ABT treatment. Data are mean 6 SD. *p < .05, by 2-way ANOVA followed by Bonferroni test. C, Western blot analysis of caspase-3 protein expression in the liver of mice exposed to 1,2-DCP, with or without 1-ABT treatment. No significant change was noted after 1,2-DCP exposure regardless of 1-ABT treatment. Data are mean 6 SD. Comparison by 2-way ANOVA followed by Bonferroni test.
Fatty changes were observed in hepatocytes of mice treated with 1-ABT, but not in 1-ABT-untreated mice. The development of fatty changes might explain the increase in liver weight observed in 1-ABT-treated mice. It is conceivable that 1-ABT does not only inhibit the activity of CYP2E1 but also inactivates other CYPs involved in lipid metabolism, such as CYP4A11, which participates in x-oxidation of long-chain fatty acids (Dierks et al., 1998; Johnson et al., 2015) . Similar effects were reported in other experiments using 1-ABT (Meschter et al., 1994; van Ravenzwaay et al., 2003; Zong et al., 2016) . Interestingly, hepatocyte fatty changes were not found in 1-ABT-treated-mice exposed to 1,2-DCP at 1250 ppm. Considering the sharp fall in body weight of these mice, the above findings suggest that 1,2-DCP might induce abnormal lipid metabolism and result in weight loss of mice after 4-week exposure.
Recent studies reported that c-H2AX, a marker of DNA double-strand breaks, was significantly increased in neoplastic lesions and non-neoplastic epithelium of bile ducts in printing workers after exposure to 1,2-DCP (Sato et al., 2014) , which was confirmed by experimental studies both in vitro and in vivo (Toyooka et al., 2017) . Hypermutation has been found in cholangiocarcinoma found in printing workers exposed to 1,2-DCP (Mimaki et al., 2016) . In the present study, we attempted to determine the DNA damage in cholangiocytes, but did not find any significant change in the expression of c-H2AX by neither immunohistochemical staining nor Western blot (Supplementary Figure 4) .
In conclusion, we demonstrated in the present study that the hepatobiliary toxic effects of 1,2-DCP appear within 4 weeks of exposure and that these effects are mediated through CYP450 in mice. 1,2-DCP also triggered cholangiocyte proliferation and apoptosis, which are considered the underlying mechanisms of carcinogenicity.
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